XNAS: ACTU
Actuate Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglu...
Read More
1.40
-0.04
(-2.78%)
139.9K
XNAS Volume
XNAS 20 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Actuate Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..